The Cooper (MEX:COO) Cyclically Adjusted Revenue per Share: MXN352.52 (As of Apr. 2026)


MEX:COO The Cooper Companies Inc MEX:COO
89 GF Score
Price MXN1,162.20
GF Value MXN1,634.26
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper Cyclically Adjusted Revenue per Share?

The Cooper MEX:COO 89 Cyclically Adjusted Revenue per Share is MXN352.52 as of Apr. 2026. GuruFocus rates MEX:COO with a GF Score™ of 89/100 and a GF Value™ of MXN1,634.26 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

The Cooper's adjusted revenue per share for the three months ended in Apr. 2026 was MXN97.147. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN352.52 for the trailing ten years ended in Apr. 2026.

During the past 12 months, The Cooper's average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of The Cooper was 18.40% per year. The lowest was -32.70% per year. And the median was 10.40% per year.

As of today (2026-07-08), The Cooper's current stock price is MXN1162.20. The Cooper's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 was MXN352.52. The Cooper's Cyclically Adjusted PS Ratio of today is 3.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of The Cooper was 9.78. The lowest was 3.28. And the median was 6.70.


The Cooper  (MEX:COO) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

The Cooper's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1162.20/352.52
=3.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of The Cooper was 9.78. The lowest was 3.28. And the median was 6.70.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


The Cooper Cyclically Adjusted Revenue per Share Related Terms


The Cooper Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for The Cooper's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Cyclically Adjusted Revenue per Share Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 223.98 386.61 306.62 320.77 317.99

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 301.09 335.11 317.99 318.72 352.52

MEX:COO vs SOLV, ALGN, BAX: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, The Cooper's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where The Cooper's Cyclically Adjusted PS Ratio falls into.


MEX:COO
89GF Score
The Cooper Companies Inc MEX:COO
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, The Cooper's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=97.147/333.0200*333.0200
=97.147

Current CPI (Apr. 2026) = 333.0200.

The Cooper Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 49.267 240.628 68.184
201610 49.414 241.729 68.076
201701 52.627 242.839 72.171
201704 49.955 244.524 68.034
201707 50.048 244.786 68.088
201710 53.812 246.663 72.652
201801 56.169 247.867 75.465
201804 59.730 250.546 79.392
201807 61.744 252.006 81.593
201810 65.981 252.885 86.889
201901 59.954 251.712 79.320
201904 62.141 255.548 80.980
201907 64.390 256.571 83.576
201910 66.304 257.346 85.801
202001 61.402 257.971 79.265
202004 63.440 256.389 82.401
202007 64.904 259.101 83.420
202010 73.093 260.388 93.481
202101 69.334 261.582 88.269
202104 72.996 267.054 91.027
202107 76.056 273.003 92.776
202110 77.846 276.589 93.729
202201 81.390 281.148 96.407
202204 84.979 289.109 97.886
202207 86.563 296.276 97.298
202210 84.673 298.012 94.620
202301 81.218 299.170 90.408
202304 79.228 303.363 86.973
202307 77.913 305.691 84.878
202310 83.852 307.671 90.761
202401 80.047 308.417 86.432
202404 80.223 313.548 85.205
202407 92.969 314.540 98.431
202410 101.644 315.664 107.233
202501 98.911 317.671 103.690
202504 97.840 320.795 101.569
202507 99.652 323.048 102.728
202510 99.666 0.000
202601 90.327 325.252 92.484
202604 97.147 333.020 97.147

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN352.52 mean?
The Cooper (MEX:COO) has a Cyclically Adjusted Revenue per Share of MXN352.52 as of Apr. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on The Cooper and its competitors.
Is The Cooper's Cyclically Adjusted Revenue per Share too high?
The Cooper's current Cyclically Adjusted Revenue per Share is MXN352.52. Overall, The Cooper has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Cyclically Adjusted Revenue per Share compare to SOLV and ALGN?
The Cooper's Cyclically Adjusted Revenue per Share of MXN352.52 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on The Cooper and its competitors. The Cooper's current Cyclically Adjusted Revenue per Share is MXN352.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (MEX:COO) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,634.26, compared to a current price of MXN1,162.20 — trading 28.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN352.52. The Cooper's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For The Cooper (MEX:COO), the current Cyclically Adjusted Revenue per Share is MXN352.52 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (MEX:COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of MXN1,162.20 is trading 28.9% below its estimated GF Value™ of MXN1,634.26. GuruFocus considers The Cooper to be Modestly Undervalued.

Key valuation signals for MEX:COO:

  • Cyclically Adjusted Revenue per Share: MXN352.52
  • GF Value™: MXN1,634.26 vs. price of MXN1,162.20 (28.9% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the MEX:COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
89GF Score

Get the complete analysis for MEX:COO

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,162.20
Price
MXN1,634.26
GF Value